Cargando…
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
Collectively, hematological malignancies account for the fourth most common malignancy. Myeloma and lymphoma are the most common types of hematological malignancies. Unfortunately, the management of refractory myeloma and lymphoma remains challenging. The discovery of new immunological therapies, na...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009535/ https://www.ncbi.nlm.nih.gov/pubmed/33814917 http://dx.doi.org/10.2147/OTT.S242018 |